Archambault AN, Su YR, Jeon J, et al. Cumulative Burden of Colorectal Cancer-Associated Genetic Variants Is More Strongly Associated With Early-Onset vs Late-Onset Cancer. Gastroenterology. 2020;158(5):1274-1286.e12. doi:10.1053/j.gastro.2019.12.012
Publications
Rao DA, Arazi A, Wofsy D, Diamond B. Design and application of single-cell RNA sequencing to study kidney immune cells in lupus nephritis. Nat Rev Nephrol. 2020;16(4):238-250. doi:10.1038/s41581-019-0232-6
Mazzilli KM, McClain KM, Lipworth L, et al. Identification of 102 Correlations between Serum Metabolites and Habitual Diet in a Metabolomics Study of the Prostate, Lung, Colorectal, and Ovarian Cancer Trial. J Nutr. 2020;150(4):694-703. doi:10.1093/jn/nxz300
Nassar AH, Alaiwi SA, AlDubayan SH, et al. Prevalence of pathogenic germline cancer risk variants in high-risk urothelial carcinoma. Genet Med. 2020;22(4):709-718. doi:10.1038/s41436-019-0720-x
Ferber S, Gonzalez RJ, Cryer AM, von Andrian UH, Artzi N. Immunology-Guided Biomaterial Design for Mucosal Cancer Vaccines. Adv Mater. 2020;32(13):e1903847. doi:10.1002/adma.201903847
Friedman S, Gauthier L, Farjoun Y, Banks E. Lean and deep models for more accurate filtering of SNP and INDEL variant calls. Bioinformatics. 2020;36(7):2060-2067. doi:10.1093/bioinformatics/btz901
Gubbels CS, VanNoy GE, Madden JA, et al. Prospective, phenotype-driven selection of critically ill neonates for rapid exome sequencing is associated with high diagnostic yield. Genet Med. 2020;22(4):736-744. doi:10.1038/s41436-019-0708-6
Cancellieri S, Canver MC, Bombieri N, Giugno R, Pinello L. CRISPRitz: rapid, high-throughput and variant-aware in silico off-target site identification for CRISPR genome editing. Bioinformatics. 2020;36(7):2001-2008. doi:10.1093/bioinformatics/btz867
Wain KE, Azzariti DR, Goldstein JL, et al. Variant interpretation is a component of clinical practice among genetic counselors in multiple specialties. Genet Med. 2020;22(4):785-792. doi:10.1038/s41436-019-0705-9
Thummalapalli R, Melms JC, Mier J, Izar B. Rapid evolution of acute kidney injury after initial infusion of pembrolizumab in a melanoma patient concurrently treated with RAF/MEK inhibitors. Melanoma Res. 2020;30(2):219-222. doi:10.1097/CMR.0000000000000646